| [1] |
Brand TM,Iida M, Li C,et a1．The nuclear epidermal growth factor receptor signaling network and its role in cancer[J].Discov Med,2011,12(66):419-32.
|
| [2] |
Ardito CM, Grüner BM, Takeuchi KK,et a1．EGF receptor is required for KRAS-induced pancreatic tumorigenesis[J]. Cancer Cell,2012,22(3):304-17.
|
| [3] |
He XJ, Jiang XT, Ma YY, et a1.REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9[J]. Cancer Sci, 2012,103(12):2082-91.
|
| [4] |
Fujisawa T, Rubin B, Suzuki A, et a1.Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer[J]. PLoS One. 2012,7(4):e34437.
|
| [5] |
Biswas DK, Cruz AP, Gansberger E,et a1. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen receptor negative breast cancer cells[J]. Proc Natl Acad Sci U S A,2000,97(15):8542-7.
|
| [6] |
Sergeant G, Lerut E, Ectors N, et al．The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder [J] Eur J Surg Oncol, 2011,37(1):80-6.
|
| [7] |
Buck E,Eyzagnirre A,Brown E,et al．Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in nonsmall- cell lung, pancreatic, colon, and breast tumors[J].Mol Cancer Ther, 2006, 5(11):2676-84.
|
| [8] |
Rocha-Lima CM, Soares HP, Raez LE,et al. EGFR targeting of solid tumors[J]. Cancer Control, 2007,14(3):295-304.
|
| [9] |
Chen WG,Long HM,Hou JQ, et al. Effects of gefitinib and small interfering RNAs targeting EGFR in the treatment of prostate cancer[J].Zhonghua Shi Yan Wai Ke Za Zhi, 2010,3(27):325-7， back insert 2.[陈卫国,龙慧民,侯建全,等.吉非替尼和靶向表皮 生长因子受体小干扰RNA治疗前列腺癌[J].中华实验外科杂 志,2010,27(3):325-7, 后插2页.]
|
| [10] |
Walsh N, Kennedy S, Larkin A,et al．EGFR and HER2 inhibition in pancreatic cancer[J]. Invest New Drugs, 2013,31(3):558-66.
|
| [11] |
Nagaraj NS, Washington MK, Merchant NB.Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth[J]. Clin Cancer Res, 2011, 17 (3):483-93.
|
| [12] |
Mysliwiec AG, Ornstein DL.Matrix metalloproteinases in colorectal cancer[J]. Clin Colorectal Cancer, 2002,1(4):208-19.
|
| [13] |
Liotta LA,Tryggvason K,Garbisa S,et a1.Metastatic potential correlates with enzymatic degradation of basement membrane collagen[J].Nature,1980,284(5751):67-8.
|
| [14] |
Lue HW, Yang X, Wang R,et a1.LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HBEGF shedding and EGFR-mediated ERK signaling[J]. PLoS One, 20 11,6(11):e27720.
|
下载:
